Par Drugs & Chemicals Ltd Share Price

Pharmaceuticals

NSE: PAR Small Cap ISIN: INE04LG01015

As on 18 November 2025 at 23:55 IST

₹94.31

+ 0.20

(0.21%)

Sell Buy

Over 1 Month

-6.76%

Over 6 Months

-11.96%

Over 1 Year

-64.83%

Over 3 Years

-43.27%

Par Drugs & Chemicals Ltd Summary

Close ₹94.11

Open ₹93.70

High ₹97.40

Low ₹93.70

Volume 10,432

Net Turnover (in Cr) ₹0.099

52Wk High -

52Wk Low -

52Wk High / Low

Par Drugs & Chemicals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹115.80

EPS (TTM) 7.87

Book Value (BV) 86.50

Div. Yield -

P/E (TTM) 11.96

Price/Book Value 1.09

Delivery % 50.49 %

Face Value 10

Key Ratios

PE Ratio 7.82

PB Ratio 1.06

EV to Sales 0.76

PEG Ratio -0.99

ROA 13.46

ROE 14.47

Debt-Equity -

Net Profit Margin 11.78

Operating Profit Margin 19.09

Par Drugs & Chemicals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	103.12	95.88	95.99	75.26	60.94
Total Expenses	85.20	76.37	80.91	62.56	48.20
Profit Before Tax	17.92	19.52	15.08	12.70	14.73
Profit After Tax	13.36	14.50	11.33	9.21	11.61
Operating Profit After Depreciation	18	19.62	15.21	13.16	13.38

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	38.91	41.31	38.45	34.10	29.91
Total Non Current Assets	64.53	41.99	39.43	35.13	35.20
Total Current Assets	54.86	59.62	49.44	43.56	41.19
Total Assets	119.39	101.61	88.87	78.69	76.38
Total Shareholder's Fund	98.97	85.63	71.24	59.88	52.21

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	16.16	20.25	13.38	7.62	12.09
Net Cash Used In Investing Activities	-25.24	-5.84	-7.34	-3.02	0.05
Net Cash Used In Financing Activities	-	-	-	-9.55	1.65

No data available

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	28.66	26.05	22.33	21.38	34.66
Total Expenses	22.59	22.49	19.90	19.96	23.25
Profit Before Tax	5.56	4.48	2.28	0.77	11.49
Profit After Tax	4.13	3.33	1.65	0.58	8.60
Operating Profit after Depreciation	6.55	5.40	3.22	1.69	12.43

Par Drugs & Chemicals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 92.74

S2 91.37

S3 89.04

Pivot 95.07

R1 96.44

R2 98.77

R3 100.14

Moving Average

20 SMA 99.54

50 SMA 103.91

100 SMA 101.91

200 SMA 108.60

Par Drugs & Chemicals Ltd Corporate Actions

Par Drugs & Chemicals Ltd

₹1.25/Share

Announcement Date 22 Nov 2021

Record Date 23 Nov 2021

Div Yield 12%

AGM Date: 29 Sep 2021

Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2021 Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication (As Per NSE Announcement dated on 02.09.2021) Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication (As per NSE Announcement Dated on 09/09/2021)

AGM Date: 10 Sep 2022

Par Drugs And Chemicals Limited has informed the Exchange about Notice of Annual General Meeting to be held on 10-Sep-2022 Par Drugs And Chemicals Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 03-Sep-2022 to 10-Sep-2022 for the purpose of Meeting. (As Per NSE Announcement Dated on 01.08.2022) Par Drugs And Chemicals Limited has informed the Exchange about Newspaper Advertisements regarding 23rd AGM Notice and e-voting information (As Per NSE Announcement Dated on 17.08.2022) Par Drugs And Chemicals Limited has informed the Exchange about Proceedings of Annual General Meeting held on 10-Sep-2022 (As Per NSE Announcement Dated on 10.09.2022) Par Drugs And Chemicals Limited has informed the Exchange about Voting results and Scrutinizer report of Annual General Meeting held on 10-Sep-2022 (As Per NSE Announcement Dated on 11.09.2022)

AGM Date: 16 Sep 2023

Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 17, 2023. Par Drugs And Chemicals Limited has informed the Exchange regarding 'Outcome of Board Meeting dated 17.08.2023'. Par Drugs And Chemicals Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 09-Sep-2023 to 16-Sep-2023 for the purpose of Meeting. Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 16, 2023 PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 16-Sep-2023 Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 16, 2023. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated on: 18/09/2023)

AGM Date: 21 Sep 2024

Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 21, 2024 Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 21, 2024 (As Per NSE Announcement Dated on: 21/09/2024) Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 21, 2024. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated on: 22/09/2024)

AGM Date: 27 Sep 2025

The Board considered and decided following particulars for ensuing 26th AGM; Meeting Number: 26th Annual General Meeting Date: 27th Day of September, 2025 Day: Saturday Venue: Hotel Tara Suns, B/h Yash Complex, B/s Sonal Park, G.E.R.I. Road, Gotri, Vadodara -390021, Gujarat, India Time: 11:00 AM IST Mode: Physical Cut-off/Record date: For the purpose of voting through remote e voting, Venue voting at the time of the AGM and attending the AGM. Friday, September 19, 2025 3. Book Closure period Saturday, 20 September, 2025 to Saturday, 27 September, 2025 4. Commencement of E-voting Tuesday, 23rd September, 2025 from 09:00 A.M. IST 5. End of e voting Friday, 26th Sept The Board decided to appoint CS Dip G. Patel, proprietor of DG Patel & Associates, Company Secretaries (FCS: 10533; COP No. 13774, Peer Review Certificate: 1839/2022) as a Scrutinizer to scrutinize the votes cast by the members through remote e-voting as well as voting during the Annual General Meeting in a fair and transparent manner. Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 27, 2025. (As Per NSE Announcement Dated On : 27.09.2025) Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 27, 2025. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated On : 28.09.2025)

EGM Date: 15 Apr 2021

Par Drugs And Chemicals Limited has informed the Exchange that the Board of Directors at its meeting held on March 18, 2021, have considered and approved bonus at the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held. Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on April 15, 2021 (As per NSE Announcement Dated on 19/03/2021) Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication (As per NSE Announcement Dated on 20/03/2021) Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication (As per NSE Announcement Dated on 24/03/2021) Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on April 15, 2021. Further, the company has informed the Exchange regarding voting results. (As per NSE Announcement dated on 15/04/2021) Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on April 15, 2021. Further, the company has informed the Exchange regarding voting results. (As per NSE Announcement dated on 16/04/2021)

EGM Date: 31 Dec 2024

Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on December 31, 2024 Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of the Extra Ordinary General Meeting dated 31.12.2024 (As Per NSE Announcement Dated on: 31/12/2024) Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on December 31, 2024 (As Per NSE Announcement Dated on: 01/01/2025)

EGM Date: 05 Feb 2025

The Board considered and decided to call an Extra Ordinary General Meeting on Wednesday 12th February, 202$ through Video Conferencing ('VC') mode/ Other Audio Visual Means ('OAVM') in accordance with the relevant circulars issued by Ministry of Corporate Affairs and Securities and Exchange Board of India. The Notice of EGM will be sent in due course.

EGM Date: 12 Feb 2025

Par Drugs And Chemicals Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on February 12, 2025 Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on February 12, 2025 (As Per NSE Announcement Dated on: 12.02.2025) Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 12, 2025 (As Per NSE Announcement Dated on: 13.02.2025)

Par Drugs & Chemicals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Par Drugs & Chemicals Ltd Top Mutal Funds Invested

No data available

Par Drugs & Chemicals Ltd News

Par Drugs & Chemicals to hold board meeting

On 13 November 2025

04 Nov 2025, 04:36 pm

Par Drugs & Chemicals to hold AGM

On 27 September 2025

04 Sep 2025, 04:01 pm

Par Drugs & Chemicals announces board meeting date

On 29 August 2025

21 Aug 2025, 11:25 am

Par Drugs & Chemicals to conduct board meeting

On 7 August 2025

30 Jul 2025, 11:35 am

Par Drugs & Chemicals announces board meeting date

On 8 May 2025

28 Apr 2025, 10:10 am

Par Drugs & Chemicals Ltd Stock Analysis

Annual revenue for Par Drugs & Chemicals Ltd increased by 7.55% to ₹103.12 crore in FY 2025 from ₹95.88 crore in FY 2024.
Annual Net Profit for Par Drugs & Chemicals Ltd decreased by 7.88% to ₹13.36 crore in FY 2025 from ₹14.50 crore in FY 2024.
Promoter Shareholding in Par Drugs & Chemicals Ltd remains unchanged by 0.00% in the most recent quarter, from 73.37% in June 2025 to 73.37% in September 2025.
Par Drugs & Chemicals Ltd delivered a 1-year return of -64.83% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Par Drugs & Chemicals Ltd share price moved up by 0.21% from its previous close of INR ₹94.11. The latest Par Drugs & Chemicals Ltd share price is INR ₹94.31.
Par Drugs & Chemicals Ltd share price today has been at a low of 92.25 and a high of 95.34. Over the past 52 weeks, the Par Drugs & Chemicals Ltd share price has seen a low of 81.01 and a high of 348.45.